Melanotan 2 (MT2), a synthetic peptide analog of α-MSH, stimulates melanin production, leading to skin tanning. The timeline for visible results varies based on several factors:
1.Typical Timeline:
○Initial Effects: Some users report noticing a tan within 3–5 days of starting injections, particularly with daily dosing and moderate UV exposure (sunlight or tanning beds).
○Full Results: A more pronounced tan typically develops over 2–3 weeks, depending on consistency of use and UV exposure.
2.Key Influencing Factors:
○Dosage and Administration: Many users begin with a "loading phase" (e.g., 0.5–1 mg daily for 10 days) followed by maintenance doses (2–3 times weekly). Higher initial doses may accelerate results but increase side effects.
○UV Exposure: Melanin produced by MT2 requires UV activation. Regular, moderate UV exposure (10–20 minutes daily) enhances tan development. Overexposure increases melanoma risk.
○Skin Type: Individuals with darker baseline skin (Fitzpatrick types III–IV) may tan faster than those with fair skin (types I–II).
○Metabolism and Genetics: Variations in individual response affect melanin synthesis speed.
3.Side Effects and Risks:
○Common side effects include nausea, facial flushing, and appetite suppression, which may influence dosing tolerance.
○Risks include uneven pigmentation, moles darkening, and potential long-term health concerns due to lack of FDA approval and limited safety studies.
4.Important Considerations:
○MT2 is not FDA-approved and is sold as a research chemical, often without quality control.
○Consult a healthcare professional before use, especially given legal and health risks.
In summary, while MT2 can produce a tan within days, optimal results typically take 2–3 weeks. Responsible use, cautious UV exposure, and awareness of risks are crucial.
